FFA
PBE icon

Farther Finance Advisors’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Farther Finance Advisors’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$822K Sell
9,174
-165
-2% -$13.6K 0.01% 1221
2026
Q1 		$743K Buy
9,339
+563
+6% +$45.5K 0.01% 1159
2025
Q4 		$721K Buy
8,776
+100
+1% +$7.74K 0.01% 1090
2025
Q3 		$606K Buy
8,676
+119
+1% +$8.04K 0.01% 978
2025
Q2 		$549K Sell
8,557
-59
-0.7% -$3.65K 0.01% 869
2025
Q1 		$535K Buy
8,616
+6,201
+257% +$417K 0.01% 757
2024
Q4 		$161K Buy
+2,415
New +$166K 0.01% 1088

Other funds holding PBE

YIA
YHB Investment Advisors West Hartford, Connecticut $1.56B AUM 27.39% 1-Year Est. Return
NDSI
Newman Dignan & Sheerar Inc Providence, Rhode Island $523M AUM 26.16% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
PA
PFG Advisors Phoenix, Arizona $1.98B AUM 28.18% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Farther Finance Advisors's PBE Position: Q2 2026 in Review

Farther Finance Advisors reduced its Invesco Biotechnology & Genome ETF (PBE) stake by 1.8% in Q2 2026, selling an estimated $13.6K and leaving 9,174 shares worth $822K. The position accounts for 0.01% of the portfolio, ranked #1221.

Farther Finance Advisors first reported a position in PBE in Q4 2024 and has held it in 7 quarters since. 9 funds tracked by Wall St. Rank hold PBE as of Q2 2026.

  • Farther Finance Advisors held 9,174 shares of Invesco Biotechnology & Genome ETF worth $822K as of Q2 2026.
  • Farther Finance Advisors sold 165 Invesco Biotechnology & Genome ETF shares in Q2 2026, an estimated $13.6K.
  • Invesco Biotechnology & Genome ETF made up 0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #1221 holding.
  • Farther Finance Advisors first reported a position in Invesco Biotechnology & Genome ETF in Q4 2024 and has held it in 7 quarters since.
  • 9 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.